Biochemical Pharmacology Discussion Group
Understanding drug action at the frontiers of modern drug design
Developing effective new drugs relies upon a deep understanding of how these chemical compounds act in isolation and in the context of the multi-faceted systems within the human body.
The Biochemical Pharmacology Discussion Group advances our fundamental knowledge of the activity and metabolism of both small molecules and biologics at the biochemical and molecular levels. Research spans chemotherapy, neuropharmacology, antimicrobials, inflammation, and immunopharmacology, as well as gastrointestinal, cardiovascular, and endocrine pharmacology and toxicology.
The group also serves as the Biochemical Topical Group for the American Chemical Society's New York Chapter.
Did you know it takes an average of 12 years for a drug to travel from lab to patient? Research and development of a single successful drug costs an estimated $2.6 billion.
Sonya Dougal, PhD
Steering Committee MembersThe Biochemical Pharmacology Discussion Group Steering Committee, composed of multi-sector and multi-institutional scientists from the Academy’s network, provides thought leadership on key issues of interest to the biochemistry, molecular biology, biomedical research, translational medicine, and related communities, helping to inform and shape our program portfolio.
Janssen Research and Development
Otsuka America Pharmaceutical, Inc.
Mount Sinai Medical Center
Weill Cornell Medical College
Global Blood Therapeutics
Regeneron Pharmaceuticals, Inc.
St. Jude Children's Research Hospital
New Jersey Economic Development Authority
Novartis Institutes for BioMedical Research
B. Riley FBR